Molecular docking and quantitative structure-activity relationships for a series of Trypanosoma cruzi dihydroorotate dehydrogenase inhibitors

Abstract Caused by the protozoan Trypanosoma cruzi, Chagas disease affects six to seven million people worldwide, mainly in Latin America. The drugs currently available for treating the disease are ineffective during its chronic phase and have serious adverse effects. Essential for the survival of T...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gabriela Ciffeli de Jesus, Tatiana Santana Ribeiro, Adriano D. Andricopulo, Leonardo Luiz Gomes Ferreira
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 2025-01-01
Edice:	Brazilian Journal of Pharmaceutical Sciences
Témata:	Trypanosoma cruzi Medicinal chemistry QSAR Dihydroorotate dehydrogenase Inhibitors Chagas disease
On-line přístup:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502025000100312&lng=en&tlng=en
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!